120 related articles for article (PubMed ID: 10818092)
1. Targeting the ets binding site of the HER2/neu promoter with pyrrole-imidazole polyamides.
Chiang SY; Burli RW; Benz CC; Gawron L; Scott GK; Dervan PB; Beerman TA
J Biol Chem; 2000 Aug; 275(32):24246-54. PubMed ID: 10818092
[TBL] [Abstract][Full Text] [Related]
2. Binding of an ETS-related protein within the DNase I hypersensitive site of the HER2/neu promoter in human breast cancer cells.
Scott GK; Daniel JC; Xiong X; Maki RA; Kabat D; Benz CC
J Biol Chem; 1994 Aug; 269(31):19848-58. PubMed ID: 7914192
[TBL] [Abstract][Full Text] [Related]
3. The epithelial-specific ETS transcription factor ESX/ESE-1/Elf-3 modulates breast cancer-associated gene expression.
Eckel KL; Tentler JJ; Cappetta GJ; Diamond SE; Gutierrez-Hartmann A
DNA Cell Biol; 2003 Feb; 22(2):79-94. PubMed ID: 12713734
[TBL] [Abstract][Full Text] [Related]
4. An upstream element containing an ETS binding site is crucial for transcription of the human presenilin-1 gene.
Pastorcic M; Das HK
J Biol Chem; 1999 Aug; 274(34):24297-307. PubMed ID: 10446206
[TBL] [Abstract][Full Text] [Related]
5. Dual regulation of ets-activated gene expression by SP1.
Kelley KM; Wang H; Ratnam M
Gene; 2003 Mar; 307():87-97. PubMed ID: 12706891
[TBL] [Abstract][Full Text] [Related]
6. Pituitary Ets-1 and GABP bind to the growth factor regulatory sites of the rat prolactin promoter.
Schweppe RE; Gutierrez-Hartmann A
Nucleic Acids Res; 2001 Mar; 29(5):1251-60. PubMed ID: 11222776
[TBL] [Abstract][Full Text] [Related]
7. ESX: a structurally unique Ets overexpressed early during human breast tumorigenesis.
Chang CH; Scott GK; Kuo WL; Xiong X; Suzdaltseva Y; Park JW; Sayre P; Erny K; Collins C; Gray JW; Benz CC
Oncogene; 1997 Apr; 14(13):1617-22. PubMed ID: 9129154
[TBL] [Abstract][Full Text] [Related]
8. Ets regulation of the erbB2 promoter.
Scott GK; Chang CH; Erny KM; Xu F; Fredericks WJ; Rauscher FJ; Thor AD; Benz CC
Oncogene; 2000 Dec; 19(55):6490-502. PubMed ID: 11175365
[TBL] [Abstract][Full Text] [Related]
9. Anti-repression of RNA polymerase II transcription by pyrrole-imidazole polyamides.
Dickinson LA; Trauger JW; Baird EE; Ghazal P; Dervan PB; Gottesfeld JM
Biochemistry; 1999 Aug; 38(33):10801-7. PubMed ID: 10451376
[TBL] [Abstract][Full Text] [Related]
10. ras oncogene-dependent activation of the P4 promoter of minute virus of mice through a proximal P4 element interacting with the Ets family of transcription factors.
Fuks F; Deleu L; Dinsart C; Rommelaere J; Faisst S
J Virol; 1996 Mar; 70(3):1331-9. PubMed ID: 8627649
[TBL] [Abstract][Full Text] [Related]
11. Antitumoral actions of the anti-obesity drug orlistat (XenicalTM) in breast cancer cells: blockade of cell cycle progression, promotion of apoptotic cell death and PEA3-mediated transcriptional repression of Her2/neu (erbB-2) oncogene.
Menendez JA; Vellon L; Lupu R
Ann Oncol; 2005 Aug; 16(8):1253-67. PubMed ID: 15870086
[TBL] [Abstract][Full Text] [Related]
12. The PEA3 Ets transcription factor is a downstream target of the HER2/Neu receptor tyrosine kinase.
O'Hagan RC; Hassell JA
Oncogene; 1998 Jan; 16(3):301-10. PubMed ID: 9467955
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of the Catalytic Telomerase Subunit by the Transcription Factor ER81 and Oncogenic HER2/Neu, Ras, or Raf.
Goueli BS; Janknecht R
Mol Cell Biol; 2004 Jan; 24(1):25-35. PubMed ID: 14673140
[TBL] [Abstract][Full Text] [Related]
14. A novel gene silencer, pyrrole-imidazole polyamide targeting human lectin-like oxidized low-density lipoprotein receptor-1 gene improves endothelial cell function.
Ueno T; Fukuda N; Tsunemi A; Yao EH; Matsuda H; Tahira K; Matsumoto T; Matsumoto K; Matsumoto Y; Nagase H; Sugiyama H; Sawamura T
J Hypertens; 2009 Mar; 27(3):508-16. PubMed ID: 19330905
[TBL] [Abstract][Full Text] [Related]
15. ETS1 and ETS2 in p53 regulation: spatial separation of ETS binding sites (EBS) modulate protein: DNA interaction.
Venanzoni MC; Robinson LR; Hodge DR; Kola I; Seth A
Oncogene; 1996 Mar; 12(6):1199-1204. PubMed ID: 8649821
[TBL] [Abstract][Full Text] [Related]
16. Regulation of Her2/neu promoter activity by the ETS transcription factor, ER81.
Bosc DG; Janknecht R
J Cell Biochem; 2002; 86(1):174-83. PubMed ID: 12112028
[TBL] [Abstract][Full Text] [Related]
17. Identification and characterization of the IKKalpha promoter: positive and negative regulation by ETS-1 and p53, respectively.
Gu L; Zhu N; Findley HW; Woods WG; Zhou M
J Biol Chem; 2004 Dec; 279(50):52141-9. PubMed ID: 15469934
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of Ets-1 DNA binding and ternary complex formation between Ets-1, NF-kappaB, and DNA by a designed DNA-binding ligand.
Dickinson LA; Trauger JW; Baird EE; Dervan PB; Graves BJ; Gottesfeld JM
J Biol Chem; 1999 Apr; 274(18):12765-73. PubMed ID: 10212261
[TBL] [Abstract][Full Text] [Related]
19. Basal transcription of the mouse sarco(endo)plasmic reticulum Ca2+-ATPase type 3 gene in endothelial cells is controlled by Ets-1 and Sp1.
Hadri L; Ozog A; Soncin F; Lompré AM
J Biol Chem; 2002 Sep; 277(39):36471-8. PubMed ID: 12119294
[TBL] [Abstract][Full Text] [Related]
20. Transactivation of GATA-1 promoter with ETS1, ETS2 and ERGB/Hu-FLI-1 proteins: stabilization of the ETS1 protein binding on GATA-1 promoter sequences by monoclonal antibody.
Seth A; Robinson L; Thompson DM; Watson DK; Papas TS
Oncogene; 1993 Jul; 8(7):1783-90. PubMed ID: 8510925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
